Skip to main content
SpringerLink
Log in

Chemistry and Structural Biology of 1,2-Interstrand Adducts of Cisplatin

  • Chapter
Platinum-Based Drugs in Cancer Therapy

Part of the book series: Cancer Drug Discovery and Development ((CDD&D))

  • 298 Accesses

Abstract

Shortly after the discovery of the cytostatic activity of cis-diamminedichloroplatinum(II) (cisplatin) (1) it was suggested that the mechanism of antitumor activity of cisplatin involves its binding to DNA (for review, see refs. 2–4). In addition, it was suggested that the mechanism of antitumor activity of cisplatin might be analogous to the biologic activity of bifunctional alkylating agents (such as nitrogen mustard), which also exhibit cytostatic effects (5). As the cytostatic effect of di-alkylating agents was generally accepted to be associated with their DNA interstrand crosslinking efficiency, the first hypotheses on the mechanism underlying the cytotoxicity of cisplatin in tumor cells were derived from its ability to form interstrand crosslinks in DNA (6). On the basis of this analogy, cisplatin was sometimes incorrectly called an “alkylating agent.”

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rosenberg, B., Van Camp, L., Trosko, J. E. and Mansour, V. H. (1969) Platinum compounds: a new class of potent antitumor agents. Nature 222, 385–386.

    Article  PubMed  CAS  Google Scholar 

  2. Kleinwächter, V. (1978) Interaction of platinum(II) coordination complexes with deoxyribonucleic acid. Studia biophys. 73, 1–17.

    Google Scholar 

  3. Roberts, J. J. and Thomson, A. J. (1979) Mechanism of action of antitumor platinum compounds. Prog. Nucleic Acid Res. Mol. Biol. 22, 71–134.

    Article  PubMed  CAS  Google Scholar 

  4. Drobník, J. (1983) Antitumor activity of platinum complexes. Cancer Chemother. Pharmacol. 10, 145–149.

    Article  PubMed  Google Scholar 

  5. Drobník, J. and Horacek, P. (1973) Specific biological activity of platinum complexes. Contribution to the theory of molecular mechanism. Chem. Biol. Interact. 7, 223–229.

    Article  PubMed  Google Scholar 

  6. Pascoe, J. M. and Roberts, J. J. (1974) Interactions between mammalian cell DNA and inorganic platinum compounds. I. DNA interstrand crosslinking and cytotoxic properties of platinum(II) compounds. Biochem. Pharmacol. 23, 1345–1357.

    Article  PubMed  CAS  Google Scholar 

  7. Johnson, N. P., Hoeschele, J. D., and Rahn, R. 0. (1980) Kinetic analysis of the in vitro binding of radioactive cis-and trans-dichlorodiammineplatinum(II) to DNA Chem. Biol. Interact. 30, 151–169.

    Article  PubMed  CAS  Google Scholar 

  8. Hansson, J. and Wood, R. D. (1989) Repair synthesis by human cell extracts in DNA damaged by cis-and trans-diamminedichloroplatinum(II). Nucleic Acids Res. 17, 8073–8092.

    Article  PubMed  CAS  Google Scholar 

  9. Jones, J. C., Zhen, W., Reed, E., Parker, R. J., Sancar, A., and Bohr, V. A. (1991) Gene-specific formation and repair of cisplatin intrastrand adducts and interstrand crosslinks in Chinese hamster ovary cells. J. Biol. Chem. 266, 7101–7107.

    PubMed  CAS  Google Scholar 

  10. Brabec, V. and Leng, M. (1993) DNA interstrand crosslinks of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues. Proc. Natl. Acad. Sci. USA 90, 5345–5349.

    Article  PubMed  CAS  Google Scholar 

  11. Vrana, 0., Boudnÿ, V., and Brabec, V. (1996) Superhelical torsion controls DNA inter-strand crosslinking by antitumor cis-diamminedichloroplatinum(II). Nucleic Acids Res. 24, 3918–3925.

    Article  Google Scholar 

  12. Zwelling, L. A., Anderson, T., and Kohn, K. W. (1979) DNA protein and DNA interstrand crosslinking by cis-and trans-platinum(II)diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity. Cancer Res. 39, 365–369.

    PubMed  CAS  Google Scholar 

  13. Pera, M. F., Rawlings, C. J., and Roberts, J. J. (1981) The role of DNA repair in the recovery of human cells form cisplatin toxicity. Chem. Biol. Interact. 37, 245–261.

    Article  PubMed  CAS  Google Scholar 

  14. Plooy, A. C.M., Van Dijk, M., and Lohman, P. H.M. (1984) Induction and repair of DNA crosslinks in Chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA cytotoxicity, mutagenicity, and antitumor activity. Cancer Res. 44, 2043–2051.

    PubMed  CAS  Google Scholar 

  15. Bedford, P., Walker, M. C., Sharma, H. L., Perera, A., M. A.liffe, C.A., Masters, J. R.W., and Hill, B. T. (1987) Factors influencing the sensitivity of two human bladder carcinoma cell lines to cis-diamminedichloroplatinum(II). Chem.Biol. Interact. 61, 1–15.

    Article  PubMed  CAS  Google Scholar 

  16. Strandberg, M. C., Bresnick, E., and Eastman, A. (1982) The significance of DNA crosslinking to cis-diamminedichloroplatinum(II)-induced cytotoxicity in sensitive and resistant lines of murine leukemia L1210 cells. Chem.Biol. Interact. 39, 169–180.

    Article  PubMed  CAS  Google Scholar 

  17. Pinto, A. L. and Lippard, S. J. (1984) Binding of the antitumor drug cisdiamminedichloroplatinum(II) (cisplatin) to DNA Biochim. Biophys. Acta 780, 167–180.

    Google Scholar 

  18. Fichtinger-Schepman, A. M. J., Van der Veer, J. L., Den Hartog, J. H. J., Lohman, P. H. M., and Reedijk, J. (1985) Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA formation, identification, and quantitation. Biochemistry 24, 707–713.

    Article  PubMed  CAS  Google Scholar 

  19. Eastman, A. (1987) The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol. Thee. 34, 155–166.

    Google Scholar 

  20. Rahmouni, A. and Leng, M. (1987) Reaction of nucleic acids with cis-diamminedichloroplatinum(II): interstrand crosslinks. Biochemistry 26, 7229–7234.

    Article  PubMed  CAS  Google Scholar 

  21. Sip, M. and Leng, M. (1993) DNA cis-platinum and intercalators: catalytic activity of the DNA double helix, in Nucleic Acids and Molecular Biology ( Eckstein, F. and Lilley, D. M.J., eds.), Springer-Verlag, Berlin, pp. 1–15.

    Chapter  Google Scholar 

  22. Eastman, A. (1985) Interstrand crosslinks and sequence specificity in the reaction of cisdichloro(ethylenediamine)platinum(II) with DNA Biochemistry 24, 5027–5032.

    CAS  Google Scholar 

  23. Castleman, H. and Erlanger, B. F. (1983) Stabilization of (dG-dC)n.(dG-dC)n in the Z conformation by a crosslinking reaction. Nucleic Acids Res. 11, 8421–8429.

    Article  PubMed  CAS  Google Scholar 

  24. Lemaire, M. A., Schwartz, A., Rahmouni, A. R., and Leng, M. (1991) Interstrand crosslinks are preferentially formed at the d(GC) sites in the reaction between cisdiamminedichloroplatinum(II) and DNA Proc. Natl Acad. Sci. USA 88, 1982–1985.

    Article  CAS  Google Scholar 

  25. Harder, H. C. and Lee, C. C. (1983) Coordination of interstrand crosslinks between polydeoxyguanylic acid and polydeoxycytidylic acid by cis-diamminedichloroplatinum(II). Cancer Res. 43, 4799–4804.

    PubMed  CAS  Google Scholar 

  26. Sherman, S. E., Gibson, D., Wang, A. H.J. and Lippard, S. J. (1988) Crystal and molecular structure of cis-[Pt(NH3)2d(pGpG)], the principal adduct formed by cisdiamminedichloroplatinum(II) with DNA J. Am. Chem. Soc. 110, 7368–7380.

    Google Scholar 

  27. Lippert, B. (1989) Platinum nucleobase chemistry. Prog. Inorg. Chem. 37, 1–97.

    Article  Google Scholar 

  28. Sip, M., Schwartz, A., Voyelle, E, Ptak, M., and Leng, M. (1992) Distortions induced in DNA by cis-platinum interstrand adducts. Biochemistry 31, 2508–2513.

    Article  PubMed  CAS  Google Scholar 

  29. Malinge, J. M., Perez, C., and Leng, M. (1994) Base sequence-independent distorsions induced by interstrand crosslinks in cis-diaminedichloroplatinum (II) modified DNA Nucleic Acids Res. 22, 3834–3839.

    CAS  Google Scholar 

  30. Huang, H. F., Zhu, L. M., Reid, B. R., Drobny, G. P., and Hopkins, P. B. (1995) Solution structure of a cisplatin-induced DNA interstrand crosslink. Science 270, 1842–1845.

    Article  PubMed  CAS  Google Scholar 

  31. Paquet, F., Perez, C., Leng, M., Lancelot, G., and Malinge, J. M. (1996) NMR solution structure of a DNA decamer containing an interstrand crosslink of the antitumor drug cisdiamminedichloroplatinum(II). J. Biomol. Struct. Dyn. 14, 67–77.

    Article  PubMed  CAS  Google Scholar 

  32. Coste, E, Malinge, J.-M., Serre, L., Shepard, W., Roth, M., Leng, M. and Zelwer, Ch. (1999) Crystal structure of a double-stranded DNA containing a cisplatin interstrand crosslink at 1.63 A resolution: hydration at the platinated site. Nucleic Acids Res. 27, 1837–1846.

    Article  PubMed  CAS  Google Scholar 

  33. Leroy, J. L., Charretier, E., Kochyian, M., and Guéron, M. (1988) Evidence from basepair kinetics for two types of adenine tract structures in solution: their reaction to DNA curvature. Biochemistry 27, 8894–8898.

    Article  PubMed  CAS  Google Scholar 

  34. Ramstein, J. and Lavery, R. (1990) Base pair opening pathways in B-DNA. J. Biomol. Struct. Dyn. 7, 915–933.

    Article  PubMed  CAS  Google Scholar 

  35. Payet, D., Gaucheron, F., Síp, M., and Leng, M. (1993) Instability of the monofunctional adducts in cis4Pt(NH3)2(N7-N-methyl-2-diazapyrenium)CIf+-modified-DNA: rates of crosslinking reactions in cis-platinum-modified DNA Nucleic Acids Res. 21, 5846–5851.

    Google Scholar 

  36. Zou, Y., Vanhouten, B., and Fanelli, N. (1994) Sequence specificity of DNA DNA inter-strand crosslink formation by cisplatin and dinuclear platinum complexes. Biochemistry 33, 5404–5410.

    Article  PubMed  CAS  Google Scholar 

  37. Gelasco, A. and Lippard, S. J. (1998) NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand crosslink, the major adduct of the anticancer drug cisplatin. Biochemistry 37, 9230–9239.

    Article  PubMed  CAS  Google Scholar 

  38. Yang, D. Z., Vanboom, S. S. G. E., Reedijk, J., Vanboom, J. H., and Wang, A. H.J. (1995) Structure and isomerization of an intrastrand cisplatin-crosslinked octamer DNA duplex by NMR analysis. Biochemistry 34, 12912–12920.

    Article  PubMed  CAS  Google Scholar 

  39. Yang, D. Z. and Wang, A. H. J. (1996) Structural studies of interactions between anticancer platinum drugs and DNA. Prog. Biophys. Mol. Biol. 66, 81–111.

    Google Scholar 

  40. Kane, S. A. and Lippard, S. J. (1996) Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific crosslinks to HMG domain proteins. Biochemistry 35, 2180–2188.

    Article  PubMed  CAS  Google Scholar 

  41. Perez, C., Leng, M., and Malinge, J. M. (1997) Rearrangement of interstrand crosslinks into intrastrand crosslinks in cis-diamminedichloroplatinum(II)-modified DNA Nucleic Acids Res. 25, 896–903.

    CAS  Google Scholar 

  42. Brabec, V., Reedijk, J., and Leng, M. (1992) Sequence-dependent distortions induced in DNA by monofunctional platinum(II) binding. Biochemistry 31, 12397–12402.

    Article  PubMed  CAS  Google Scholar 

  43. Van Garderen, C. J., Van den Elst, H., Van Boom, J. H., Reedijk, J., and Van Houte, L. P.A. (1989) A double-stranded DNA fragment shows a significant decrease in double-helix stability after binding of monofunctional platinum amine compounds. J. Am. Chem. Soc. 111, 4123–4125.

    Article  Google Scholar 

  44. Brabec, V., Boudnÿ, V. and Balcarova, Z. (1994) Monofunctional adducts of platinum(II) produce in DNA a sequence-dependent local denaturation. Biochemisty 32, 1316–1322.

    Article  Google Scholar 

  45. Lippard, S. J. and Hoeschele, J. D. (1979) Binding of cis-dichlorodiammineplatinum(II) and trans-dichlorodiammineplatinum(II) to the nucleosome core. Proc. Natl Acad. Sci. USA 76, 6091–6095.

    Article  PubMed  CAS  Google Scholar 

  46. Tullius, T. D. and Lippard, S. J. (1981) cis-Diamminedichloroplatinum(II) binds in a unique manner to oligo(dG).oligo(dC) sequences in DNA-a new assay using exonuclease III. J. Am. Chem. Soc. 103, 4620–4622.

    Google Scholar 

  47. Schwartz, A., Sip, M., and Leng, M. (1990) Sodium cyanide-a chemical probe of the conformation of DNA modified by the antitumor drug cis-diamminedichloroplatinum(II). J. Am. Chem. Soc. 112, 3673–3674.

    Article  CAS  Google Scholar 

  48. Ciccarelli, R. B., Solomon, M. J., Varshaysky, A., and Lippard, S. J. (1985) In vivo effects of cis-and trans-diamminedichloroplatinum(II) on SV 40 chromosomes: differential repair, DNA protein crosslinking, and inhibition of replication. Biochemistry 24, 7533–7540.

    Article  PubMed  CAS  Google Scholar 

  49. Chu, G. and Chang, E. (1988) Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA Science 242, 564–567.

    CAS  Google Scholar 

  50. Donahue, B. A., Augot, M., Bellon, S. F., Treiber, D. K., Toney, J.H., Lippard, S. J., and Essigmann, J. M. (1990) Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin. Biochemistry 29, 5872–5880.

    Article  PubMed  CAS  Google Scholar 

  51. Andrews, P. A. and Jones, J. A. (1991) Characterization of binding proteins from ovarian carcinoma and kidney tubule cells that are specific for cisplatin modified DNA Cancer Commun. 3, 1–10.

    CAS  Google Scholar 

  52. Chao, C. C.-K., Huang, S. L., Lee, L.Y., and Lin-Chao, S. (1991) Identification of inducible damage-recognition proteins that are overexpressed in HeLa cells resistant to cisdiamminedichloroplatinum(II). Biochem. J. 277, 875–878.

    Google Scholar 

  53. Toney, J. H., Donahue, B. A., Kellett, P. J., Bruhn, S. L., Essigmann, J.M., and Lippard, S. J. (1989) Isolation of cDNAs encoding a human protein that binds selectively to DNA modified by the anticancer drug cis-diamminedichloroplatinum(II). Proc. Natl Acad. Sci. USA. 86, 8328–8332.

    Google Scholar 

  54. Bruhn, S. L., Pil, P. M., Essigmann, J. M., Housman, D. E., and Lippard, S. J. (1992) Isolation and characterization of human cDNA clones encoding a high mobility group box protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatin. Proc. Natl Acad. Sci. USA. 89, 2307–2311.

    Article  PubMed  CAS  Google Scholar 

  55. Pil, P. M. and Lippard, S. J. (1992) Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin. Science 256, 234–237.

    Article  PubMed  CAS  Google Scholar 

  56. Bustin, M. and Reeves, R. (1996) High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog. Nucleic Acid Res. Mol. Biol. 54, 35–100.

    Article  PubMed  CAS  Google Scholar 

  57. Zlatanova, J., Yaneva, J., and Leuba, S. H. (1998) Proteins that specifically recognize cisplatin-damaged DNA: a clue to anticancer activity of cisplatin. FASEB J. 12, 791–799.

    PubMed  CAS  Google Scholar 

  58. Kaspârkovâ, J. and Brabec, V. (1995) Recognition of DNA interstrand crosslinks of cisdiamminedichloroplatinum(II) and its trans isomer by DNA binding proteins. Biochemistry 34, 12379–12387.

    Article  PubMed  Google Scholar 

  59. Duckett, D. R., Murchie, A. I. H., Bhattacharyya, A., Clegg, R. M., Diekmann, S., Von Kitzing, E., and Lilley, D. M. J. (1992) The structure of DNA junctions, and their interactions with enzymes. Eur. J. Biochem. 207, 285–295.

    Article  CAS  Google Scholar 

  60. Murchie, A. I.H. and Lilley, D. M.J. (1993) T4 endonuclease VII cleaves DNA containing a cisplatin adduct. J. Mol. Biol. 233, 77–82.

    Article  PubMed  CAS  Google Scholar 

  61. Bruhn, S. L., Housman, D. E., and Lippard, S. J. (1993) Isolation and characterization of cDNA clones encoding the Drosophila homolog of the HMG-box SSRP family that recognizes specific DNA structures. Nucleic Acids Res. 21, 1643–1646.

    Article  PubMed  CAS  Google Scholar 

  62. Lilley, D. M.J. (1996) Cisplatin adducts in DNA: distortion and recognition. J. Biol. lnorg. Chem. 1, 189–191.

    Article  CAS  Google Scholar 

  63. Rice, J. A., Crothers, D. M., Pinto, A. L., and Lippard, S. J. (1988) The major adduct of the antitumor drug cis-diamminedichloroplatinum(II) with DNA bends the duplex by —40° toward the major groove. Proc. Natl Acad. Sci. USA. 85, 4158–4161.

    Article  PubMed  CAS  Google Scholar 

  64. Bellon, S. F. and Lippard, S. J. (1990) Bending studies of DNA site-specifically modified by cisplatin, trans-diamminedichloroplatinum(II) and cis-[Pt(NH3)2(N3-cytosine)C11+. Biophys. Chem. 35, 179–188.

    Google Scholar 

  65. Yang, D. Z., Van Boom, S. S. G. E., Reedijk, J., Van Boom, J. H., and Wang, A. H. J. (1995) Structure and isomerization of an intrastrand cisplatin-crosslinked octamer DNA duplex by NMR analysis. Biochemistry 34, 12912–12920.

    Article  PubMed  CAS  Google Scholar 

  66. Bellon, S. F. Coleman, J. H., and Lippard, S. J. (1991) DNA unwinding produced by site-specific intrastrand crosslinks of the antitumor drug cis-diamminedichloroplatinum(II). Biochemistry 30, 8026–8035.

    Article  PubMed  CAS  Google Scholar 

  67. Brabec, V., Kleinwachter, V., Butour, J. L., and Johnson, N. P. (1990) Biophysical studies of the modification of DNA by antitumour platinum coordination complexes. Biophys. Chem. 35, 129–1411.

    Article  PubMed  CAS  Google Scholar 

  68. Den Hartog, J. H. J., Altona, C., Van Boom, J. H., Van der Marel, G.A., Haasnoot, C. A.G., and Reedijk, J. (1985) cis-Diamminedichloroplatinum(II) induced distortion of a single and double stranded deoxydecanucleosidemonophosphates studied by nuclear magnetic resonance. J. Biomol. Struct. Dyn. 2, 1137–1155.

    Google Scholar 

  69. Sherman, S. E. and Lippard, S. J. (1987) Structural aspects of platinum anticancer drug interactions with DNA Chem. Rev. 87, 1153–1181.

    Article  CAS  Google Scholar 

  70. Huang, J. C., Zambie, D. B., Reardon, J. T., Lippard, S. J., and Sancar, A. (1994) HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease. Proc. Natl Acad. Sci. USA. 91, 10394–10398.

    Article  PubMed  CAS  Google Scholar 

  71. Anin, M. F. and Leng, M. (1990) Distortions induced in double-stranded oligonucleotides by the binding of cis-diamminedichloroplatinum(II) or trans-diamminedichloroplatinum(II) to the d(GTG) sequence. Nucleic Acids Res. 18, 4395–4400.

    Article  PubMed  CAS  Google Scholar 

  72. Marrot, L. and Leng, M. (1989) Chemical probes of the conformation of DNA modified by cis-diamminedichloroplatinum(II). Biochemistry 28, 1454–1461.

    Article  PubMed  CAS  Google Scholar 

  73. Van Garderen, C. J. and Van Houte, L. P.A. (1994) The solution structure of a DNA duplex containing the cis-Pt(NH3)2[d(GTG)N7(G),N7(G)] adduct, as determined with high-field NMR and molecular mechanics/dynamics. Eur. J Biochem. 225, 1169–1179.

    Article  PubMed  Google Scholar 

  74. Brabec, V., gíp, M. and Leng, M. (1993) DNA conformational distortion produced by site-specific interstrand crosslink of trans-diamminedichloroplatinum(II). Biochemistry 32, 11676–11681.

    Article  PubMed  CAS  Google Scholar 

  75. Takahara, P. M., Frederick, C. A. and Lippard, S. J. (1996) Crystal structure of the anticancer drug cisplatin bound to duplex DNA J. Am. Chem. Soc. 118, 12309–12321.

    Article  CAS  Google Scholar 

  76. Marples, B., Adomat, H., Billings, F. C., Farrell, N. P., Koch, C. J., and Skov, K. A. (1994) Recognition of platinum-induced DNA damage by nuclear proteins: screening for mechanisms. Anti-Cancer Drug Design 9, 389–399.

    PubMed  CAS  Google Scholar 

  77. Turchi, J. J., Li, M., and Henkels, K. M. (1996) Cisplatin-DNA binding specificity of calf high-mobility group 1 protein. Biochemistry 35, 2992–3000.

    Article  PubMed  CAS  Google Scholar 

  78. Whitehead, J. P. and Lippard, S. J. (1996) Proteins that bind to and mediate the biological activity of platinum drug-DNA adducts, in Metal Ions in Biological Systems ( Siegel, A. and Siegel, H., eds.), Marcel Dekker, New York, pp. 687–726.

    Google Scholar 

  79. Chaney, S. G. and Sancar, A. (1996) DNA repair: enzymatic mechanisms and relevance to drug response. J Nall Cancer Inst. 88, 1346–1360.

    Article  CAS  Google Scholar 

  80. Sancar, A. (1996) DNA excision repair. Annu. Rev. Biochem. 65, 43–81.

    Article  PubMed  CAS  Google Scholar 

  81. Naegeli, H. (1997) Mechanisms of DNA Damage Recognition in Mammalian Cells. Springer-Verlag, New York.

    Google Scholar 

  82. Zambie, D. B., Mu, D., Reardon, J. T., Sancar, A., and Lippard, S. J. (1996) Repair of cisplatin-DNA adducts by the mammalian excision nuclease. Biochemistry 35, 10004–10013.

    Article  Google Scholar 

  83. Plooy, A. C.M., Van Dijk, M., Berends, F., and Lohman, P. H. M. (1985) Formation and repair of DNA interstrand crosslinks in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II). Cancer Res. 45, 4178–4184.

    PubMed  CAS  Google Scholar 

  84. Dijt, F. J., Fichtinger-Schepman, A. M. J., Berends, F., and Reedijk, J. (1988) Formation and repair of cisplatin-induced adducts to DNA in cultured normal and repair-deficient human fibroblasts. Cancer Res. 48, 6058–6062.

    PubMed  CAS  Google Scholar 

  85. Fujiwara, Y., Tatsumi, M., and Sasaki, M. S. (1977) J. Mol. Biol. 113, 635–649.

    Article  PubMed  CAS  Google Scholar 

  86. Calsou, P., Frit, P., and Salles, B. (1992) Repair synthesis by human cell extracts in cisplatin-damaged DNA is prefentially determined by minor adducts. Nucleic Acids Res. 20, 6363–6368.

    Article  PubMed  CAS  Google Scholar 

  87. Bessho, T., Mu, D., and Sancar, A. (1997) Initiation of DNA interstrand crosslink repair in humans: the nucleotide excision repair system makes dual incisions 5’ to the crosslinked base and removes a 22- to 28-nucleotide-long damage-free strand. Mol. Cell. Biol. 17, 6822–6830.

    PubMed  CAS  Google Scholar 

  88. Berardini, M., Mackay, W., and Loechler, E. L. (1997) Evidence for a recombination-independent pathway for the repair of DNA interstrand crosslinks based on a site-specific study with nitrogen mustard. Biochemistry 36, 3506–3513.

    Article  PubMed  CAS  Google Scholar 

  89. Corda, Y., Job, C., Anin, M. F., Leng, M., and Job, D. (1991) Transcription by eucaryotic and procaryotic RNA polymerases of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichioroplatinum(II). Biochemistry 30, 222–230.

    Article  PubMed  CAS  Google Scholar 

  90. Zhen, W. P., Link, C. J., O’Connor, P. M., Reed, E., Parker, R., Howell, S. B., and Bohr, V. A. (1992) Increased gene-speciflic repair of cisplatin interstrand crosslinks in cisplatinresistant human ovarian cancer cell lines. Mol. Cell. Biol. 12, 3689–3698.

    PubMed  CAS  Google Scholar 

  91. Larminat, F., Zhen, W., and Bohr, V. A. (1993) Gene-specific DNA repair of interstrand crosslinks induced by chemotherapeutic agents can be preferential. J. Biol. Chem. 268, 2649–2654.

    PubMed  CAS  Google Scholar 

  92. Johnson, S. W., Perez, R. P., Godwin, A. K., Yeung, A. T., Handel, L.M., Ozols, R. F., and Hamilton, T. C. (1994) Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines. Biochem. Pharmacol. 47, 689–697.

    Article  PubMed  CAS  Google Scholar 

  93. Larminat, F. and Bohr, V. A. (1994) Role of the human ERCC-1 gene in gene-specific repair of cisplatin-induced DNA damage. Nucleic Acids Res. 22, 3005–3010.

    Article  PubMed  CAS  Google Scholar 

  94. Stanzione, S., Cimoli, G., Debernardis, D., Michelotti, A., Conte, P.F., Parodi, S., and Russo, P. (1995) Interferon-a or ß potentiate platinum analogous in human glioblastoma cell lines. Mutat. Res. 348, 131–135.

    Article  PubMed  CAS  Google Scholar 

  95. Yang, L. Y., Li, L., Keating, M. J., and Plunkett, W. (1995) Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA crosslink repair. Mol. Pharmacol. 47, 1072–1079.

    PubMed  CAS  Google Scholar 

  96. Li, L., Keating, M. J., Plunkett, W., and Yang, L. Y. (1997) Fludarabine-mediated repair inhibition of cisplatin-induced DNA lesions in human chronic myelogenous leukemia-blast crisis K562 cells: induction of synergistic cytotoxicity independent of reversal of apoptosis resistance. Mol. Pharmacol. 52, 798–806.

    PubMed  CAS  Google Scholar 

  97. Li, L., Liu, X. M., Glassman, A. B., Keating, M. J., Stros, M., Plunkett, W., and Yang, L. Y. (1997) Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro. Cancer Res. 57, 1487–1494.

    PubMed  CAS  Google Scholar 

  98. Farrell, N., Qu, Y., Feng, L., and Van Houten, B. (1990) Comparison of chemical reactivity, cytotoxicity, interstrand crosslinking and DNA sequence specificity of bis(platinum) complexes containing monodentate or bidentate coordination spheres with their monomeric analogues. Biochemistry 29, 9522–9531.

    Article  PubMed  CAS  Google Scholar 

  99. Hoeschele, J. D., Kraker, A. J., Qu, Y., Van Houten, B., and Farrell, N. (1990) Bis(platinum) complexes, chemistry, antitumor activity and DNA binding, in Molecular Basis of Specificity in Nucleic Acid-Drug Interactions ( Pullman, B. and Jortner, J., eds.), Academic, Dordrecht, pp. 301–321.

    Chapter  Google Scholar 

  100. Farrell, N. (1991) Structurally novel platinum antitumor compounds, in Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy ( Howell, S. B., ed.), Plenum, New York, pp. 81–91.

    Google Scholar 

  101. Zaludovâ, R., Zâkovskâ, A., Kapârkovâ, J., Balcarovâ, Z., Kleinwächter, V., Vrâna, O., Farrell, N., and Brabec, V. (1997) DNA interactions of bifunctional dinuclear platinum(II) antitumor agents. Eur. J. Biochem. 246, 508–517.

    Article  PubMed  Google Scholar 

  102. Zou, Y., Van Houten, B., and Farrell, N. (1993) Ligand effects in platinum binding to DNA A comparison of DNA binding properties for cis-and trans-[PtCl2(amine)2] (amine = NH3, pyridine). Biochemistry 32, 9632–9638.

    Google Scholar 

  103. A., Novâkovâ, O., Balcarovâ, Z., Bierbach, U., Farrell, N., and Brabec, V. (1998) DNA interactions of antitumor trans-[PtCl2(NH3)(quinoline)]. Eur. J. Biochem. 254, 547–557.

    Google Scholar 

Download references

Authors
  1. Viktor Brabec
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. CRC Centre for Cancer Therapeutics, The Institute of Cancer Research, UK

    Lloyd R. Kelland

  2. Department of Chemistry, Virginia Commonwealth University, USA

    Nicholas P. Farrell

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Brabec, V. (2000). Chemistry and Structural Biology of 1,2-Interstrand Adducts of Cisplatin. In: Kelland, L.R., Farrell, N.P. (eds) Platinum-Based Drugs in Cancer Therapy. Cancer Drug Discovery and Development. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-012-4_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-012-4_2

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-091-5

  • Online ISBN: 978-1-59259-012-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation